|
DDX59 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.651234704525E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
7.78139999990657E-07 |
| Normal-vs-Stage3 |
5.558500E-03 |
| Normal-vs-Stage4 |
2.247600E-02 |
| Stage1-vs-Stage2 |
1.535840E-01 |
| Stage1-vs-Stage3 |
1.505920E-02 |
| Stage1-vs-Stage4 |
1.351630E-01 |
| Stage2-vs-Stage3 |
3.124000E-01 |
| Stage2-vs-Stage4 |
7.062400E-01 |
| Stage3-vs-Stage4 |
6.651600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95399252334028E-14 |
| Normal-vs-AfricanAmerican |
7.24631465942593E-12 |
| Normal-vs-Asian |
7.68060000000403E-05 |
| Caucasian-vs-AfricanAmerican |
8.886600E-01 |
| Caucasian-vs-Asian |
9.160400E-01 |
| AfricanAmerican-vs-Asian |
9.475800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66133814775094E-16 |
| Normal-vs-Female |
5.39349999995054E-07 |
| Male-vs-Female |
1.518330E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.19469999957123E-07 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-16 |
| Normal-vs-Obese |
2.91879964642305E-10 |
| Normal-vs-Extreme_Obese |
1.482660E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.032970E-01 |
| Normal_Weight-vs-Obese |
8.928400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.981000E-01 |
| Extreme_Weight-vs-Obese |
5.824200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.869200E-01 |
| Obese-vs-Extreme_Obese |
8.326400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.443500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.79776202205539E-12 |
| Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(81-100Yrs) |
6.40899555648389E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.616000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.790270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.616900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.145800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.576070E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.506810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
5.28910004682359E-09 |
| Normal-VS-KIRP CIMP |
1.905210E-01 |
| Normal-VS-Unclassified PRCC |
1.95612999999151E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.793600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.199500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.127900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.255600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.459400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.046400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.25517390820096E-12 |
| Normal-vs-N1 |
2.247000E-01 |
| Normal-vs-N2 |
9.15909999954501E-07 |
| N0-vs-N1 |
4.982500E-03 |
| N0-vs-N2 |
4.074000E-01 |
| N1-vs-N2 |
7.698100E-02 |
|
|
